New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 6, 2012
07:22 EDTPPG, BBOX, IIVI, KMT, STBA, FCF, EQT, MYL, HSY, ATI, FSTR, MATW, MSA, CCC, XCFA Society of Pittsburgh to host a conference
INVESTPennsylvania Equity Conference is being held in Pittsburgh on December 6.
News For MSA;MYL;IIVI;MATW;EQT;BBOX;FSTR;FCF;PPG;ATI;STBA;X;HSY;KMT;CCC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
December 12, 2014
09:32 EDTKMTKennametal shares may respond negatively to weaker trends, says Wells Fargo
Subscribe for More Information
09:19 EDTKMTKennametal reports consolidated orders up 4% in three months end November
Subscribe for More Information
07:23 EDTHSYCredit Suisse to hold a conference
Subscribe for More Information
December 11, 2014
10:13 EDTMATWOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:51 EDTHSYCredit Suisse to hold a conference
Subscribe for More Information
07:32 EDTMYLMylan launches generic version of Hikma Maple's Robaxin injection
Subscribe for More Information
07:30 EDTIIVIDA Davidson to hold a conference
6th Annual Aerospace & Industrials 1:1 Conference is being held in Boston on December 11.
07:06 EDTMYLMylan launches generic version of Orapred ODT
Mylan announced the U.S. launch of its Prednisolone Sodium Phosphate Orally Disintegrating Tablets, 10 mg, 15 mg, and 30 mg. This product is the first generic version of Shionogi's Orapred ODT. Mylan received final approval from the FDA for its Abbreviated New Drug Application for Prednisolone Sodium Phosphate Orally Disintegrating Tablets, 10 mg, 15 mg, and 30 mg, and was awarded 180 days of generic drug marketing exclusivity. This product is indicated as an anti-inflammatory or immunosuppressive agent for certain conditions; and also for the treatment of certain endocrine conditions, and for palliation of certain neoplastic conditions. Prednisolone Sodium Phosphate Orally Disintegrating Tablets had U.S. sales of approximately $19.9M for the 12 months ending September 30.
06:27 EDTMATWMatthews initiated with a Neutral at Macquarie
Target $51.
December 10, 2014
10:00 EDTEQTOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:38 EDTMYLMylan launches generic version of Pfizer's Celebrex capsules
Mylan (MYL) announced the U.S. launch of its Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg, one of the first available generic versions of Pfizer's (PFE) Celebrex Capsules, indicated for the relief of the signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, and for the management of acute pain in adults. Celecoxib Capsules had U.S. sales of approximately $2.5B for the 12 months ending September 30, 2014.
07:22 EDTEQTEQT Corporation upgraded to Buy from Accumulate at KLR Group
Subscribe for More Information
December 9, 2014
12:33 EDTPPGPPG Industries management to meet with Jefferies
Subscribe for More Information
10:50 EDTPPGPPG Industries to supply Gulfstream windows, assemblies for G500, G600 jets
Subscribe for More Information
09:38 EDTXActive equity options trading
Subscribe for More Information
December 8, 2014
11:30 EDTMYLLeerink generics pharmaceutical analyst holds analyst/industry conference call
Subscribe for More Information
07:31 EDTEQTEQT Corporation plans registration statement for EQT Midstream Partners
Subscribe for More Information
07:08 EDTEQTEQT Midstream Partners sees 2015 adjusted EBITDA $330M-$345M
Subscribe for More Information
07:06 EDTEQTEQT Corporation sees 2015 sales volume 575 600 Bcfe
Subscribe for More Information
07:04 EDTEQTEQT Corporation sees 2015 capital expenditures $2.5B
EQT Corporation (EQT) announced the companys 2015 capital expenditure forecast of $2.5B, excluding business development and land acquisitions. The CAPEX forecast includes $2.3B for EQT Production and $225M-$250M for EQT Midstream depending on the timing of an expected drop-down. Funding will be provided by cash generated from operations, cash-on-hand, and proceeds from midstream asset sales to EQT Midstream Partners, LP (EQM). EQTs 2015 CAPEX forecast excludes CAPEX for EQT Midstream Partners, LP, a master limited partnership controlled by EQT Corporation and consolidated in EQTs financial statements.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use